AI CDI & utilization review
Ranked firstBest overall for enterprise concurrent CDI at scale
41/50
1st of 6
| Capture accuracy | Traceability & auditability | Revenue & denial impact | EHR & deployment | Access & transparency |
|---|---|---|---|---|
| 9/10 | 8/10 | 9/10 | 10/10 | 5/10 |
- Best for
- Mid-sized and large hospitals that need AI cognitive emulation and chart prioritization to point a finite CDI team at the inpatient charts with the highest DRG and severity opportunity.
- Limitation
- Enterprise procurement only, with no published pricing and no self-serve evaluation path for small practices.
- Price
- Enterprise, sales-led; no published rate
Dimension-by-dimension rubric criteria for AI CDI and utilization review
- Capture accuracy9/10
Category high: 9/10
How reliably the tool finds genuine documentation gaps — diagnosis specificity, HCC recapture, severity and acuity capture — without flooding reviewers with false positives.
- Traceability & auditability8/10
Category high: 10/10
Whether every suggested code or query anchors to a verbatim phrase in the record, and whether the audit trail would survive a payer or RAC review.
- Revenue & denial impact9/10
Category high: 9/10
Documented effect on case mix index, DRG accuracy, denial rates and appeal outcomes, weighted toward externally reported results over vendor claims.
- EHR & deployment10/10
Category high: 10/10
Depth of EHR integration, concurrent versus retrospective review support, reviewer worklist prioritization, and the implementation burden on IT and HIM.
- Access & transparency5/10
Category high: 8/10
Published pricing, evaluation path, and whether a clinician or a small group can trial the tool without an enterprise procurement cycle.